SCHEMBL2965087

SCHEMBL2965087

Nc1ncnc2c1c(I)nn2CCCc1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 5/20 0.42
PIK3CG P48736 4/20 0.42
PIK3CA P42336 3/20 0.42
PIK3CB P42338 3/20 0.42
CYP2A6 P11509 1/20 0.42
PRKDC P78527 2/20 0.41
HRH1 P35367 2/20 0.40
SRC P12931 2/20 0.40
KDR P35968 2/20 0.40
PI4KB Q9UBF8 2/20 0.40
ABL1 P00519 1/20 0.40
EGFR P00533 1/20 0.40
HCK P08631 1/20 0.40
MTOR P42345 1/20 0.40
EPHB4 P54760 1/20 0.40
PRMT5 O14744 2/20 0.39
RET P07949 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CDC7 O00311 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3832902 0.86 ALDH1A1 (0.47) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL16701733 0.84 CHRM2 (0.42) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL23063891 0.78 SRC (0.46) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL19283009 0.76 ADK (0.49) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL30404896 0.75 ADK (0.46) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL21293809 0.75 ADORA2A (0.48) PIK3CDPIK3CGSRCKDRRET
SCHEMBL20553120 0.75 ADK (0.46) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL4828016 0.75 SRC (0.46) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL25678087 0.74 RET (0.52) PIK3CDPIK3CGSRCKDRRET
SCHEMBL16701523 0.73 ADK (0.49) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973917-B1 PROTEIN KINASE INHIBITORS ABBVIE INC (US) 2015-06-10 EP disclosed
US-7772231-B2 Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors ABBOTT LABORATORIES (US) 2010-08-10 US disclosed
EP-1973917-A2 PROTEIN KINASE INHIBITORS Abbott Laboratories (US) 2008-10-01 EP disclosed
US-20070203143-A1 PROTEIN KINASE INHIBITORS ABBVIE INC. 2007-08-30 US disclosed
WO-2007079164-A2 PROTEIN KINASE INHIBITORS ABBOTT LABORATORIES (US) 2007-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203143-A1 PROTEIN KINASE INHIBITORS PACSIN2, MAP3K20, PHKG1 PIK3CD 264/4885PIK3CG 299/4885PIK3CA 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.